Activation of circulating platelets and platelet response to activating agents in children with cyanotic congenital heart disease: Their relevance to palliative systemic-pulmonary shunt

International Journal of Cardiology

Volumn 79, Issue 1, 2001, Pages 49-59

  Kierzkowska, Beata ^a   Stańczyk, Jerzy ^a   Wiectawska, Boguslawa ^a   Rózalski, Marcin ^a   Boncler, Magdalena ^a   Chrul, Slawomir ^a   Watala, Cezary ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cyanotic congenital heart disease; Flow cytometry; Glycoprotein Ib ; Modified Blalock Taussig shunt (MBTS); P selectin; Palliative systemic pulmonary anastomosis; Platelet reactivity

Indexed keywords

ADENOSINE DIPHOSPHATE; GLYCOPROTEIN IB; GLYCOPROTEIN IIIA; HEMOGLOBIN; PADGEM PROTEIN; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ALLELE; ARTERIAL OXYGEN SATURATION; ARTICLE; BLALOCK TAUSSIG ANASTOMOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DEGRANULATION; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GENOTYPE; HEMATOCRIT; HUMAN; INFANT; LUNG ARTERIOVENOUS SHUNT; MALE; MEAN CORPUSCULAR HEMOGLOBIN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

BLOOD VESSEL PROSTHESIS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MALE; PEPTIDE FRAGMENTS; PLATELET ACTIVATION; POLYMORPHISM, GENETIC;

EID: 0034994608     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(01)00404-1     Document Type: Article

References (22)

1. Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease
2. Platelet activation in congenital heart diseases
3. Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass
4. Preoperative and postoperative platelet function in cyanotic congenital heart disease
5. Platelet kinetics in congenital heart disease
6. Pre- and post-operative studies of fibrinolysis and prothrombin in cyanotic congenital hearat disease
7. Thrombolyse von modifizierten Blalock-Taussig-Shunts im Kindesalter mit rekombinantem Gewebeplasminogenaktivator
8. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function
9. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study
10. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists
11. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ib alpha involved in platelet transfusion refractoriness
12. The largest variant of platelet glycoprotein Ib alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine 145
13. Membrane lipid fluidity of blood platelets: A common denominator underlying the opposite actions of various agents affecting platelet activation in whole blood
14. Haemostatic defects in cyanotic congenital heart disease
15. Cyclic fluctuations in platelet count, megakaryocyte maturation and thrombopoietin activity in cyanotic congenital heart disease
16. Heparinschock mit Verbrauchsreaktion des Blutgerinnungssystems?
17. Metabolism of platelets
18. Correction of platelet dysfunction and bleeding in cyanotic congenital heart disease by simple red cell volume reduction
19. Is platelet heterogeneity due to ageing or thrombopoiesis
20. Cyanotic congenital heart disease in children: Hemostatic disorders and relevance of molecular markers of hemostasis
21. Defective platelet aggregation in patients undergoing surgical repair of cyanotic congenital heart disease